Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratins Antikörper (PE)

Dieses Anti--Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von in ICFC. Geeignet für Säugetier. Dieses Primary Antibody wurde in 5+ Publikationen zitiert.
Produktnummer ABIN192048

Kurzübersicht für Cytokeratins Antikörper (PE) (ABIN192048)

Target

Cytokeratins

Reaktivität

Säugetier

Wirt

  • 4
Maus

Klonalität

  • 4
Monoklonal

Konjugat

  • 1
  • 1
  • 1
  • 1
PE

Applikation

  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Intracellular Flow Cytometry (ICFC)

Klon

C-11
  • Verwendungszweck

    Anti-Cytokeratins PE

    Spezifität

    The antibody C-11 reacts with cytokeratin peptides 4, 5, 6, 8, 10, 13, 18. Cytokeratins are members of intermediate filaments subfamily intracellular proteins represented in epithelial tissues.

    Kreuzreaktivität (Details)

    Mammalian

    Aufreinigung

    Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

    Immunogen

    Keratin-enriched preparation from human epidermoid carcinoma cell line A431.

    Isotyp

    IgG1
  • Applikationshinweise

    Flow cytometry: Recommended dilution: 1 μg/mL. Intracellular staining.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Do not freeze.
    Avoid prolonged exposure to light.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
  • Petry, Kippenberger, Meissner, Kleemann, Kaufmann, Rieger, Wellenbrock, Reichenbach, Zöller, Valesky: "Directing adipose-derived stem cells into keratinocyte-like cells: impact of medium composition and culture condition." in: Journal of the European Academy of Dermatology and Venereology : JEADV, Vol. 32, Issue 11, pp. 2010-2019, (2019) (PubMed).

    Broekema, Harmsen, Koerts, Petersen, van Luyn, Navis, Popa: "Determinants of tubular bone marrow-derived cell engraftment after renal ischemia/reperfusion in rats." in: Kidney international, Vol. 68, Issue 6, pp. 2572-81, (2005) (PubMed).

    Hamakawa, Sumida, Tanioka, Sogawa, Yamada: "Extraction of cytokeratin from the human submandibular gland and its electrophoretic analysis." in: Research communications in molecular pathology and pharmacology, Vol. 101, Issue 2, pp. 115-26, (1999) (PubMed).

    Bártek, Vojt?sek, Stasková, Bártková, Kerekés, Rejthar, Kovarík: "A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology." in: The Journal of pathology, Vol. 164, Issue 3, pp. 215-24, (1991) (PubMed).

    Kovarík, Rejthar, Lauerová, Vojt?sek, Bártková: "Monoclonal antibodies against individual cytokeratins in the detection of metastatic spread." in: International journal of cancer. Supplement = Journal international du cancer. Supplement, Vol. 3, pp. 50-5, (1989) (PubMed).

  • Target

    Cytokeratins

    Hintergrund

    Cytokeratins are a subfamily of intermediate filaments and are characterized by remarkable biochemical diversity. They are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individual cytokeratin polypeptides are designated 1 to 20 and divided into the type I (acidic cytokeratins 9-20) and type II (basic to neutral cytokeratins 1-8) families.,cytokeratin, CYK, CK, KRT
Sie sind hier:
Chat with us!